Dr. Jee Youn Moon from Seoul discusses neuromodulation therapy for cancer pain, emphasizing the importance of correct indication and timing. Neuropathic cancer pain—caused by tumor progression, chemotherapy, or radiation—is...
This talk highlights the effectiveness and underutilization of the MILD procedure—now formally known as Percutaneous Interlaminar Lumbar Decompression—in treating lumbar spinal stenosis with neurogenic claudication. With over 110,000 cases...
This presentation addresses cancer-related abdominal and pelvic pain managementthrough interventional procedures targeting sympathetic pathways.
Dr. Ale reviews indications for splenic nerve neurolysis and celiac plexus block, especially for upper abdominal malignancies...
This panel discussion brings together leaders from numerous pain and neuromodulation societies worldwide to address fragmentation within the field. The conversation highlights the diversity of missions among societies like...
This presentation focuses on precision targeted drug delivery (TDD) for cancer pain management, emphasizing recent advances in dosing strategies and intrathecal pharmacology. Dr. Hermant Kalia highlights three core pillars...
In this insightful talk, Dr. Charles Argoff emphasizes the continued importance of pharmacotherapy in headache and migraine treatment. He critiques outdated perceptions and advocates for open-minded, patient-specific approaches that integrate...
This presentation reviews the updated 2022 CDC opioid prescribing guidelines and their impact on pain management. It outlines the consequences of the 2016 guidelines—such as abrupt discontinuation, rigid dose...
This presentation explores the unique healthcare challenges in the U.S. military and veteran systems. Drawing from 15 years of military medical experience, the speaker highlights critical distinctions between the...
This presentation introduces the concept of osteogenic pain, emphasizing that bone is more than a structural tissue—it is richly innervated with nociceptive fibers, making it a significant pain generator....
Dr. Corey Hunter discusses the evolving landscape of neuromodulation for chronic pain management. Highlighting the shift from limited options pre-2015 to today's expanding field, he emphasizes individualized therapy selection...
This presentation highlights the concept of biotensegrity—the interconnected nature of muscles, ligaments, fascia, and joints—and its role in chronic pain management. Dr. George Chien emphasizes that pain often arises...
This panel brings together top executives from leading neuromodulation and minimally invasive spine companies to discuss the current and future state of interventional pain therapies. Each leader shares insights...
Dr. Cory Hunter, President of NANS, presents an in-depth overview of closed-loop spinal cord stimulation (SCS) and the breakthrough potential of ECAP-controlled therapy. He contrasts traditional open-loop systems with...
This panel brings together Chief Medical Officers (CMOs) from both startups and large medtech companies to discuss their roles, experiences, and advice for physicians considering a similar career path....
This presentation explores the multifaceted role of size in neuromodulation, from electrode spacing and lead configurations to IPG dimensions, waveform characteristics, and energy delivery. Dr. Valimahomed discusses how different...
In this insightful lecture, Dr. Leonardo Kapural reflects on 13 years of contributions to the Mediterranean Pain Forum and presents cutting-edge advancements in neuromodulation. Highlighting data from multiple studies,...
Dr. Andrew Kaufman presents a comprehensive review of spinal cord stimulation (SCS) for visceral pain, including anginal, abdominal, pancreatic, and pelvic pain. He discusses the complexity of visceral pain...
This talk addresses salvage strategies for spinal cord stimulation (SCS), focusing on patients who experience loss of efficacy, unwanted sensations, or recharge difficulties. Traditional responses like reprogramming, stimulation holidays,...
In this comprehensive lecture, Dr. Robert Rapcan explores the combination of regenerative therapy and mechanical techniques for treating discogenic pain. He emphasizes that stem cell injections alone may not...
This presentation offers an insightful overview of the current landscape and investment trends in pain neuromodulation, spanning implantable and non-invasive technologies. While spinal cord stimulation (SCS) remains dominant by...
Dr. Lorand Eross discusses the potential for spinal cord stimulation (SCS) beyond therapy. He reviews the common forms of SCS stimulus and reviews novel approaches to SCS stimulation, including fast-acting sub-threshold stimulation, contour stimulation, and combination therapy. He highlights differential target multiplexed stimulation and its ability to change ion channels through gene expression modulation, as well as closed loop SCS and ARC therapy to restore functionality. Dr. Eross analyzes the progress made in neuromodulation over the past 20 years and compares it to developments in brain-computer interface (BCI) technology. He details the interesting area of research exploring BCI for neuromodulation.
Dr. Jee Youn Moon from Seoul discusses neuromodulation therapy for cancer pain, emphasizing the importance of correct indication and timing. Neuropathic cancer pain—caused by tumor progression, chemotherapy, or radiation—is...
This talk highlights the effectiveness and underutilization of the MILD procedure—now formally known as Percutaneous Interlaminar Lumbar Decompression—in treating lumbar spinal stenosis with neurogenic claudication. With over 110,000 cases...
This presentation addresses cancer-related abdominal and pelvic pain managementthrough interventional procedures targeting sympathetic pathways.
Dr. Ale reviews indications for splenic nerve neurolysis and celiac plexus block, especially for upper abdominal malignancies...
This panel discussion brings together leaders from numerous pain and neuromodulation societies worldwide to address fragmentation within the field. The conversation highlights the diversity of missions among societies like...
This presentation focuses on precision targeted drug delivery (TDD) for cancer pain management, emphasizing recent advances in dosing strategies and intrathecal pharmacology. Dr. Hermant Kalia highlights three core pillars...
In this insightful talk, Dr. Charles Argoff emphasizes the continued importance of pharmacotherapy in headache and migraine treatment. He critiques outdated perceptions and advocates for open-minded, patient-specific approaches that integrate...
This presentation reviews the updated 2022 CDC opioid prescribing guidelines and their impact on pain management. It outlines the consequences of the 2016 guidelines—such as abrupt discontinuation, rigid dose...
This presentation explores the unique healthcare challenges in the U.S. military and veteran systems. Drawing from 15 years of military medical experience, the speaker highlights critical distinctions between the...
This presentation introduces the concept of osteogenic pain, emphasizing that bone is more than a structural tissue—it is richly innervated with nociceptive fibers, making it a significant pain generator....
Dr. Corey Hunter discusses the evolving landscape of neuromodulation for chronic pain management. Highlighting the shift from limited options pre-2015 to today's expanding field, he emphasizes individualized therapy selection...
This presentation highlights the concept of biotensegrity—the interconnected nature of muscles, ligaments, fascia, and joints—and its role in chronic pain management. Dr. George Chien emphasizes that pain often arises...
This panel brings together top executives from leading neuromodulation and minimally invasive spine companies to discuss the current and future state of interventional pain therapies. Each leader shares insights...
Dr. Cory Hunter, President of NANS, presents an in-depth overview of closed-loop spinal cord stimulation (SCS) and the breakthrough potential of ECAP-controlled therapy. He contrasts traditional open-loop systems with...
This panel brings together Chief Medical Officers (CMOs) from both startups and large medtech companies to discuss their roles, experiences, and advice for physicians considering a similar career path....
This presentation explores the multifaceted role of size in neuromodulation, from electrode spacing and lead configurations to IPG dimensions, waveform characteristics, and energy delivery. Dr. Valimahomed discusses how different...
In this insightful lecture, Dr. Leonardo Kapural reflects on 13 years of contributions to the Mediterranean Pain Forum and presents cutting-edge advancements in neuromodulation. Highlighting data from multiple studies,...
Dr. Andrew Kaufman presents a comprehensive review of spinal cord stimulation (SCS) for visceral pain, including anginal, abdominal, pancreatic, and pelvic pain. He discusses the complexity of visceral pain...
This talk addresses salvage strategies for spinal cord stimulation (SCS), focusing on patients who experience loss of efficacy, unwanted sensations, or recharge difficulties. Traditional responses like reprogramming, stimulation holidays,...
In this comprehensive lecture, Dr. Robert Rapcan explores the combination of regenerative therapy and mechanical techniques for treating discogenic pain. He emphasizes that stem cell injections alone may not...
This presentation offers an insightful overview of the current landscape and investment trends in pain neuromodulation, spanning implantable and non-invasive technologies. While spinal cord stimulation (SCS) remains dominant by...